20/20 Biolabs, Inc. (AIDX)
0.5349
+0.02
(+3.22%)
USD |
NASDAQ |
Aug 25, 15:48
20/20 Biolabs Gross Profit Margin (Quarterly) : 41.71% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 41.71% |
| March 31, 2026 | 17.80% |
| December 31, 2025 | 24.22% |
| September 30, 2025 | 34.71% |
| March 31, 2025 | 29.94% |
| Date | Value |
|---|---|
| December 31, 2024 | 30.40% |
| September 30, 2024 | 6.68% |
| June 30, 2023 | 11.64% |
| March 31, 2023 | 0.45% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Sanara MedTech, Inc. | 90.76% |
| Intelligent Bio Solutions, Inc. | 21.68% |
| Anteris Technologies Global Corp. | 30.43% |
| Quest Diagnostics, Inc. | 32.53% |
| Labcorp Holdings, Inc. | 27.71% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -387.3% |
| Return on Assets | -120.5% |
| Return on Invested Capital | -232.1% |
| Profit Margin (Quarterly) | -206.2% |
| Operating Margin (Quarterly) | -170.3% |
| Return on Net Operating Assets | -391.8% |